Medical Devices & Consumables
Global Inactivated Poultry Vaccines Market Research Report 2025
- May 12, 25
- ID: 242584
- Pages: 106
- Figures: 101
- Views: 1
The global market for Inactivated Poultry Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Inactivated Poultry Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inactivated Poultry Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inactivated Poultry Vaccines include MSD Animal Health, Hester Biosciences, Vaxxinova, Elanco, Dechra, Kemin Industries, Ceva, Venkys, HIPRA, Japfa Comfeed, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Poultry Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Poultry Vaccines.
The Inactivated Poultry Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Poultry Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Poultry Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MSD Animal Health
Hester Biosciences
Vaxxinova
Elanco
Dechra
Kemin Industries
Ceva
Venkys
HIPRA
Japfa Comfeed
Boehringer Ingelheim
Zoetis
Nisseiken
KM Biologics
Laprovet
Merck
Segment by Type
Whole Cell Vaccine
Component Vaccine
Segment by Application
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Poultry Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inactivated Poultry Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Inactivated Poultry Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inactivated Poultry Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inactivated Poultry Vaccines include MSD Animal Health, Hester Biosciences, Vaxxinova, Elanco, Dechra, Kemin Industries, Ceva, Venkys, HIPRA, Japfa Comfeed, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Poultry Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Poultry Vaccines.
The Inactivated Poultry Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Poultry Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Poultry Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MSD Animal Health
Hester Biosciences
Vaxxinova
Elanco
Dechra
Kemin Industries
Ceva
Venkys
HIPRA
Japfa Comfeed
Boehringer Ingelheim
Zoetis
Nisseiken
KM Biologics
Laprovet
Merck
Segment by Type
Whole Cell Vaccine
Component Vaccine
Segment by Application
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Poultry Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inactivated Poultry Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Inactivated Poultry Vaccines Market Overview
1.1 Product Definition
1.2 Inactivated Poultry Vaccines by Type
1.2.1 Global Inactivated Poultry Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Whole Cell Vaccine
1.2.3 Component Vaccine
1.3 Inactivated Poultry Vaccines by Application
1.3.1 Global Inactivated Poultry Vaccines Market Value by Application (2024 VS 2031)
1.3.2 NDV
1.3.3 Marek ' s Disease
1.3.4 IBD
1.3.5 Infectious Bronchitis
1.3.6 Influenza
1.3.7 Others
1.4 Global Inactivated Poultry Vaccines Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poultry Vaccines Revenue 2020-2031
1.4.2 Global Inactivated Poultry Vaccines Sales 2020-2031
1.4.3 Global Inactivated Poultry Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Poultry Vaccines Market Competition by Manufacturers
2.1 Global Inactivated Poultry Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Poultry Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Poultry Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Poultry Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Poultry Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Poultry Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Poultry Vaccines, Date of Enter into This Industry
2.8 Global Inactivated Poultry Vaccines Market Competitive Situation and Trends
2.8.1 Global Inactivated Poultry Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Poultry Vaccines Players Market Share by Revenue
2.8.3 Global Inactivated Poultry Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Poultry Vaccines Market Scenario by Region
3.1 Global Inactivated Poultry Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Poultry Vaccines Sales by Region: 2020-2031
3.2.1 Global Inactivated Poultry Vaccines Sales by Region: 2020-2025
3.2.2 Global Inactivated Poultry Vaccines Sales by Region: 2026-2031
3.3 Global Inactivated Poultry Vaccines Revenue by Region: 2020-2031
3.3.1 Global Inactivated Poultry Vaccines Revenue by Region: 2020-2025
3.3.2 Global Inactivated Poultry Vaccines Revenue by Region: 2026-2031
3.4 North America Inactivated Poultry Vaccines Market Facts & Figures by Country
3.4.1 North America Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.4.3 North America Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Poultry Vaccines Market Facts & Figures by Country
3.5.1 Europe Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.5.3 Europe Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Poultry Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Poultry Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Poultry Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Poultry Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inactivated Poultry Vaccines Market Facts & Figures by Country
3.7.1 Latin America Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Poultry Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inactivated Poultry Vaccines Sales by Type (2020-2031)
4.1.1 Global Inactivated Poultry Vaccines Sales by Type (2020-2025)
4.1.2 Global Inactivated Poultry Vaccines Sales by Type (2026-2031)
4.1.3 Global Inactivated Poultry Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Poultry Vaccines Revenue by Type (2020-2031)
4.2.1 Global Inactivated Poultry Vaccines Revenue by Type (2020-2025)
4.2.2 Global Inactivated Poultry Vaccines Revenue by Type (2026-2031)
4.2.3 Global Inactivated Poultry Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Poultry Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Poultry Vaccines Sales by Application (2020-2031)
5.1.1 Global Inactivated Poultry Vaccines Sales by Application (2020-2025)
5.1.2 Global Inactivated Poultry Vaccines Sales by Application (2026-2031)
5.1.3 Global Inactivated Poultry Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Poultry Vaccines Revenue by Application (2020-2031)
5.2.1 Global Inactivated Poultry Vaccines Revenue by Application (2020-2025)
5.2.2 Global Inactivated Poultry Vaccines Revenue by Application (2026-2031)
5.2.3 Global Inactivated Poultry Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Poultry Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MSD Animal Health Inactivated Poultry Vaccines Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Hester Biosciences
6.2.1 Hester Biosciences Company Information
6.2.2 Hester Biosciences Description and Business Overview
6.2.3 Hester Biosciences Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hester Biosciences Inactivated Poultry Vaccines Product Portfolio
6.2.5 Hester Biosciences Recent Developments/Updates
6.3 Vaxxinova
6.3.1 Vaxxinova Company Information
6.3.2 Vaxxinova Description and Business Overview
6.3.3 Vaxxinova Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Vaxxinova Inactivated Poultry Vaccines Product Portfolio
6.3.5 Vaxxinova Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Company Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Inactivated Poultry Vaccines Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Dechra
6.5.1 Dechra Company Information
6.5.2 Dechra Description and Business Overview
6.5.3 Dechra Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dechra Inactivated Poultry Vaccines Product Portfolio
6.5.5 Dechra Recent Developments/Updates
6.6 Kemin Industries
6.6.1 Kemin Industries Company Information
6.6.2 Kemin Industries Description and Business Overview
6.6.3 Kemin Industries Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kemin Industries Inactivated Poultry Vaccines Product Portfolio
6.6.5 Kemin Industries Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Inactivated Poultry Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Venkys
6.8.1 Venkys Company Information
6.8.2 Venkys Description and Business Overview
6.8.3 Venkys Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Venkys Inactivated Poultry Vaccines Product Portfolio
6.8.5 Venkys Recent Developments/Updates
6.9 HIPRA
6.9.1 HIPRA Company Information
6.9.2 HIPRA Description and Business Overview
6.9.3 HIPRA Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 HIPRA Inactivated Poultry Vaccines Product Portfolio
6.9.5 HIPRA Recent Developments/Updates
6.10 Japfa Comfeed
6.10.1 Japfa Comfeed Company Information
6.10.2 Japfa Comfeed Description and Business Overview
6.10.3 Japfa Comfeed Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Japfa Comfeed Inactivated Poultry Vaccines Product Portfolio
6.10.5 Japfa Comfeed Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Company Information
6.11.2 Boehringer Ingelheim Description and Business Overview
6.11.3 Boehringer Ingelheim Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boehringer Ingelheim Inactivated Poultry Vaccines Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Zoetis
6.12.1 Zoetis Company Information
6.12.2 Zoetis Description and Business Overview
6.12.3 Zoetis Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zoetis Inactivated Poultry Vaccines Product Portfolio
6.12.5 Zoetis Recent Developments/Updates
6.13 Nisseiken
6.13.1 Nisseiken Company Information
6.13.2 Nisseiken Description and Business Overview
6.13.3 Nisseiken Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nisseiken Inactivated Poultry Vaccines Product Portfolio
6.13.5 Nisseiken Recent Developments/Updates
6.14 KM Biologics
6.14.1 KM Biologics Company Information
6.14.2 KM Biologics Description and Business Overview
6.14.3 KM Biologics Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 KM Biologics Inactivated Poultry Vaccines Product Portfolio
6.14.5 KM Biologics Recent Developments/Updates
6.15 Laprovet
6.15.1 Laprovet Company Information
6.15.2 Laprovet Description and Business Overview
6.15.3 Laprovet Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Laprovet Inactivated Poultry Vaccines Product Portfolio
6.15.5 Laprovet Recent Developments/Updates
6.16 Merck
6.16.1 Merck Company Information
6.16.2 Merck Description and Business Overview
6.16.3 Merck Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Merck Inactivated Poultry Vaccines Product Portfolio
6.16.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Poultry Vaccines Industry Chain Analysis
7.2 Inactivated Poultry Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Poultry Vaccines Production Mode & Process Analysis
7.4 Inactivated Poultry Vaccines Sales and Marketing
7.4.1 Inactivated Poultry Vaccines Sales Channels
7.4.2 Inactivated Poultry Vaccines Distributors
7.5 Inactivated Poultry Vaccines Customer Analysis
8 Inactivated Poultry Vaccines Market Dynamics
8.1 Inactivated Poultry Vaccines Industry Trends
8.2 Inactivated Poultry Vaccines Market Drivers
8.3 Inactivated Poultry Vaccines Market Challenges
8.4 Inactivated Poultry Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Inactivated Poultry Vaccines by Type
1.2.1 Global Inactivated Poultry Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Whole Cell Vaccine
1.2.3 Component Vaccine
1.3 Inactivated Poultry Vaccines by Application
1.3.1 Global Inactivated Poultry Vaccines Market Value by Application (2024 VS 2031)
1.3.2 NDV
1.3.3 Marek ' s Disease
1.3.4 IBD
1.3.5 Infectious Bronchitis
1.3.6 Influenza
1.3.7 Others
1.4 Global Inactivated Poultry Vaccines Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poultry Vaccines Revenue 2020-2031
1.4.2 Global Inactivated Poultry Vaccines Sales 2020-2031
1.4.3 Global Inactivated Poultry Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Poultry Vaccines Market Competition by Manufacturers
2.1 Global Inactivated Poultry Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Poultry Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Poultry Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Poultry Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Poultry Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Poultry Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Poultry Vaccines, Date of Enter into This Industry
2.8 Global Inactivated Poultry Vaccines Market Competitive Situation and Trends
2.8.1 Global Inactivated Poultry Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Poultry Vaccines Players Market Share by Revenue
2.8.3 Global Inactivated Poultry Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Poultry Vaccines Market Scenario by Region
3.1 Global Inactivated Poultry Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Poultry Vaccines Sales by Region: 2020-2031
3.2.1 Global Inactivated Poultry Vaccines Sales by Region: 2020-2025
3.2.2 Global Inactivated Poultry Vaccines Sales by Region: 2026-2031
3.3 Global Inactivated Poultry Vaccines Revenue by Region: 2020-2031
3.3.1 Global Inactivated Poultry Vaccines Revenue by Region: 2020-2025
3.3.2 Global Inactivated Poultry Vaccines Revenue by Region: 2026-2031
3.4 North America Inactivated Poultry Vaccines Market Facts & Figures by Country
3.4.1 North America Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.4.3 North America Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Poultry Vaccines Market Facts & Figures by Country
3.5.1 Europe Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.5.3 Europe Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Poultry Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Poultry Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Poultry Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Poultry Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inactivated Poultry Vaccines Market Facts & Figures by Country
3.7.1 Latin America Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Poultry Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Poultry Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Poultry Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Poultry Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inactivated Poultry Vaccines Sales by Type (2020-2031)
4.1.1 Global Inactivated Poultry Vaccines Sales by Type (2020-2025)
4.1.2 Global Inactivated Poultry Vaccines Sales by Type (2026-2031)
4.1.3 Global Inactivated Poultry Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Poultry Vaccines Revenue by Type (2020-2031)
4.2.1 Global Inactivated Poultry Vaccines Revenue by Type (2020-2025)
4.2.2 Global Inactivated Poultry Vaccines Revenue by Type (2026-2031)
4.2.3 Global Inactivated Poultry Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Poultry Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Poultry Vaccines Sales by Application (2020-2031)
5.1.1 Global Inactivated Poultry Vaccines Sales by Application (2020-2025)
5.1.2 Global Inactivated Poultry Vaccines Sales by Application (2026-2031)
5.1.3 Global Inactivated Poultry Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Poultry Vaccines Revenue by Application (2020-2031)
5.2.1 Global Inactivated Poultry Vaccines Revenue by Application (2020-2025)
5.2.2 Global Inactivated Poultry Vaccines Revenue by Application (2026-2031)
5.2.3 Global Inactivated Poultry Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Poultry Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MSD Animal Health Inactivated Poultry Vaccines Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Hester Biosciences
6.2.1 Hester Biosciences Company Information
6.2.2 Hester Biosciences Description and Business Overview
6.2.3 Hester Biosciences Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hester Biosciences Inactivated Poultry Vaccines Product Portfolio
6.2.5 Hester Biosciences Recent Developments/Updates
6.3 Vaxxinova
6.3.1 Vaxxinova Company Information
6.3.2 Vaxxinova Description and Business Overview
6.3.3 Vaxxinova Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Vaxxinova Inactivated Poultry Vaccines Product Portfolio
6.3.5 Vaxxinova Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Company Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Inactivated Poultry Vaccines Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Dechra
6.5.1 Dechra Company Information
6.5.2 Dechra Description and Business Overview
6.5.3 Dechra Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dechra Inactivated Poultry Vaccines Product Portfolio
6.5.5 Dechra Recent Developments/Updates
6.6 Kemin Industries
6.6.1 Kemin Industries Company Information
6.6.2 Kemin Industries Description and Business Overview
6.6.3 Kemin Industries Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kemin Industries Inactivated Poultry Vaccines Product Portfolio
6.6.5 Kemin Industries Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Inactivated Poultry Vaccines Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Venkys
6.8.1 Venkys Company Information
6.8.2 Venkys Description and Business Overview
6.8.3 Venkys Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Venkys Inactivated Poultry Vaccines Product Portfolio
6.8.5 Venkys Recent Developments/Updates
6.9 HIPRA
6.9.1 HIPRA Company Information
6.9.2 HIPRA Description and Business Overview
6.9.3 HIPRA Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 HIPRA Inactivated Poultry Vaccines Product Portfolio
6.9.5 HIPRA Recent Developments/Updates
6.10 Japfa Comfeed
6.10.1 Japfa Comfeed Company Information
6.10.2 Japfa Comfeed Description and Business Overview
6.10.3 Japfa Comfeed Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Japfa Comfeed Inactivated Poultry Vaccines Product Portfolio
6.10.5 Japfa Comfeed Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Company Information
6.11.2 Boehringer Ingelheim Description and Business Overview
6.11.3 Boehringer Ingelheim Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boehringer Ingelheim Inactivated Poultry Vaccines Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Zoetis
6.12.1 Zoetis Company Information
6.12.2 Zoetis Description and Business Overview
6.12.3 Zoetis Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zoetis Inactivated Poultry Vaccines Product Portfolio
6.12.5 Zoetis Recent Developments/Updates
6.13 Nisseiken
6.13.1 Nisseiken Company Information
6.13.2 Nisseiken Description and Business Overview
6.13.3 Nisseiken Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nisseiken Inactivated Poultry Vaccines Product Portfolio
6.13.5 Nisseiken Recent Developments/Updates
6.14 KM Biologics
6.14.1 KM Biologics Company Information
6.14.2 KM Biologics Description and Business Overview
6.14.3 KM Biologics Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 KM Biologics Inactivated Poultry Vaccines Product Portfolio
6.14.5 KM Biologics Recent Developments/Updates
6.15 Laprovet
6.15.1 Laprovet Company Information
6.15.2 Laprovet Description and Business Overview
6.15.3 Laprovet Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Laprovet Inactivated Poultry Vaccines Product Portfolio
6.15.5 Laprovet Recent Developments/Updates
6.16 Merck
6.16.1 Merck Company Information
6.16.2 Merck Description and Business Overview
6.16.3 Merck Inactivated Poultry Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Merck Inactivated Poultry Vaccines Product Portfolio
6.16.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Poultry Vaccines Industry Chain Analysis
7.2 Inactivated Poultry Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Poultry Vaccines Production Mode & Process Analysis
7.4 Inactivated Poultry Vaccines Sales and Marketing
7.4.1 Inactivated Poultry Vaccines Sales Channels
7.4.2 Inactivated Poultry Vaccines Distributors
7.5 Inactivated Poultry Vaccines Customer Analysis
8 Inactivated Poultry Vaccines Market Dynamics
8.1 Inactivated Poultry Vaccines Industry Trends
8.2 Inactivated Poultry Vaccines Market Drivers
8.3 Inactivated Poultry Vaccines Market Challenges
8.4 Inactivated Poultry Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Inactivated Poultry Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Inactivated Poultry Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Inactivated Poultry Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Inactivated Poultry Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Inactivated Poultry Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Inactivated Poultry Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Inactivated Poultry Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Inactivated Poultry Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inactivated Poultry Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Poultry Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Poultry Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Poultry Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poultry Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Poultry Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Inactivated Poultry Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Inactivated Poultry Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Inactivated Poultry Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Inactivated Poultry Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Inactivated Poultry Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Inactivated Poultry Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Inactivated Poultry Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Inactivated Poultry Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Inactivated Poultry Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Inactivated Poultry Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Inactivated Poultry Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Inactivated Poultry Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Inactivated Poultry Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Inactivated Poultry Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Inactivated Poultry Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Inactivated Poultry Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Inactivated Poultry Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Inactivated Poultry Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Inactivated Poultry Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Inactivated Poultry Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Inactivated Poultry Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Inactivated Poultry Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Inactivated Poultry Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Inactivated Poultry Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Inactivated Poultry Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Inactivated Poultry Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Inactivated Poultry Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Inactivated Poultry Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Inactivated Poultry Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. MSD Animal Health Company Information
Table 71. MSD Animal Health Description and Business Overview
Table 72. MSD Animal Health Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. MSD Animal Health Inactivated Poultry Vaccines Product
Table 74. MSD Animal Health Recent Developments/Updates
Table 75. Hester Biosciences Company Information
Table 76. Hester Biosciences Description and Business Overview
Table 77. Hester Biosciences Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Hester Biosciences Inactivated Poultry Vaccines Product
Table 79. Hester Biosciences Recent Developments/Updates
Table 80. Vaxxinova Company Information
Table 81. Vaxxinova Description and Business Overview
Table 82. Vaxxinova Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Vaxxinova Inactivated Poultry Vaccines Product
Table 84. Vaxxinova Recent Developments/Updates
Table 85. Elanco Company Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Elanco Inactivated Poultry Vaccines Product
Table 89. Elanco Recent Developments/Updates
Table 90. Dechra Company Information
Table 91. Dechra Description and Business Overview
Table 92. Dechra Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Dechra Inactivated Poultry Vaccines Product
Table 94. Dechra Recent Developments/Updates
Table 95. Kemin Industries Company Information
Table 96. Kemin Industries Description and Business Overview
Table 97. Kemin Industries Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Kemin Industries Inactivated Poultry Vaccines Product
Table 99. Kemin Industries Recent Developments/Updates
Table 100. Ceva Company Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ceva Inactivated Poultry Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Venkys Company Information
Table 106. Venkys Description and Business Overview
Table 107. Venkys Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Venkys Inactivated Poultry Vaccines Product
Table 109. Venkys Recent Developments/Updates
Table 110. HIPRA Company Information
Table 111. HIPRA Description and Business Overview
Table 112. HIPRA Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. HIPRA Inactivated Poultry Vaccines Product
Table 114. HIPRA Recent Developments/Updates
Table 115. Japfa Comfeed Company Information
Table 116. Japfa Comfeed Description and Business Overview
Table 117. Japfa Comfeed Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Japfa Comfeed Inactivated Poultry Vaccines Product
Table 119. Japfa Comfeed Recent Developments/Updates
Table 120. Boehringer Ingelheim Company Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Boehringer Ingelheim Inactivated Poultry Vaccines Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Zoetis Company Information
Table 126. Zoetis Description and Business Overview
Table 127. Zoetis Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zoetis Inactivated Poultry Vaccines Product
Table 129. Zoetis Recent Developments/Updates
Table 130. Nisseiken Company Information
Table 131. Nisseiken Description and Business Overview
Table 132. Nisseiken Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Nisseiken Inactivated Poultry Vaccines Product
Table 134. Nisseiken Recent Developments/Updates
Table 135. KM Biologics Company Information
Table 136. KM Biologics Description and Business Overview
Table 137. KM Biologics Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. KM Biologics Inactivated Poultry Vaccines Product
Table 139. KM Biologics Recent Developments/Updates
Table 140. Laprovet Company Information
Table 141. Laprovet Description and Business Overview
Table 142. Laprovet Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Laprovet Inactivated Poultry Vaccines Product
Table 144. Laprovet Recent Developments/Updates
Table 145. Merck Company Information
Table 146. Merck Description and Business Overview
Table 147. Merck Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Merck Inactivated Poultry Vaccines Product
Table 149. Merck Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Inactivated Poultry Vaccines Distributors List
Table 153. Inactivated Poultry Vaccines Customers List
Table 154. Inactivated Poultry Vaccines Market Trends
Table 155. Inactivated Poultry Vaccines Market Drivers
Table 156. Inactivated Poultry Vaccines Market Challenges
Table 157. Inactivated Poultry Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Poultry Vaccines
Figure 2. Global Inactivated Poultry Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inactivated Poultry Vaccines Market Share by Type: 2024 & 2031
Figure 4. Whole Cell Vaccine Product Picture
Figure 5. Component Vaccine Product Picture
Figure 6. Global Inactivated Poultry Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Inactivated Poultry Vaccines Market Share by Application: 2024 & 2031
Figure 8. NDV
Figure 9. Marek ' s Disease
Figure 10. IBD
Figure 11. Infectious Bronchitis
Figure 12. Influenza
Figure 13. Others
Figure 14. Global Inactivated Poultry Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Inactivated Poultry Vaccines Market Size (2020-2031) & (US$ Million)
Figure 16. Global Inactivated Poultry Vaccines Sales (2020-2031) & (K Units)
Figure 17. Global Inactivated Poultry Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 18. Inactivated Poultry Vaccines Report Years Considered
Figure 19. Inactivated Poultry Vaccines Sales Share by Manufacturers in 2024
Figure 20. Global Inactivated Poultry Vaccines Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Inactivated Poultry Vaccines Players: Market Share by Revenue in Inactivated Poultry Vaccines in 2024
Figure 22. Inactivated Poultry Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Inactivated Poultry Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 25. North America Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. United States Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 29. Europe Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 30. Germany Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Inactivated Poultry Vaccines Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Inactivated Poultry Vaccines Revenue Market Share by Region (2020-2031)
Figure 37. China Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 45. Latin America Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Inactivated Poultry Vaccines by Type (2020-2031)
Figure 55. Global Revenue Market Share of Inactivated Poultry Vaccines by Type (2020-2031)
Figure 56. Global Inactivated Poultry Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Inactivated Poultry Vaccines by Application (2020-2031)
Figure 58. Global Revenue Market Share of Inactivated Poultry Vaccines by Application (2020-2031)
Figure 59. Global Inactivated Poultry Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 60. Inactivated Poultry Vaccines Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Inactivated Poultry Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Inactivated Poultry Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Inactivated Poultry Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Inactivated Poultry Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Inactivated Poultry Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Inactivated Poultry Vaccines Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Inactivated Poultry Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Inactivated Poultry Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inactivated Poultry Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Poultry Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Poultry Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Poultry Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poultry Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Poultry Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Inactivated Poultry Vaccines Sales by Region (2020-2025) & (K Units)
Table 18. Global Inactivated Poultry Vaccines Sales Market Share by Region (2020-2025)
Table 19. Global Inactivated Poultry Vaccines Sales by Region (2026-2031) & (K Units)
Table 20. Global Inactivated Poultry Vaccines Sales Market Share by Region (2026-2031)
Table 21. Global Inactivated Poultry Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Inactivated Poultry Vaccines Revenue Market Share by Region (2020-2025)
Table 23. Global Inactivated Poultry Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Inactivated Poultry Vaccines Revenue Market Share by Region (2026-2031)
Table 25. North America Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 27. North America Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 28. North America Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 32. Europe Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 33. Europe Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Inactivated Poultry Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Inactivated Poultry Vaccines Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Inactivated Poultry Vaccines Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Inactivated Poultry Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Inactivated Poultry Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Inactivated Poultry Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Inactivated Poultry Vaccines Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Inactivated Poultry Vaccines Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Inactivated Poultry Vaccines Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Inactivated Poultry Vaccines Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Inactivated Poultry Vaccines Sales (K Units) by Type (2020-2025)
Table 51. Global Inactivated Poultry Vaccines Sales (K Units) by Type (2026-2031)
Table 52. Global Inactivated Poultry Vaccines Sales Market Share by Type (2020-2025)
Table 53. Global Inactivated Poultry Vaccines Sales Market Share by Type (2026-2031)
Table 54. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Inactivated Poultry Vaccines Revenue Market Share by Type (2020-2025)
Table 57. Global Inactivated Poultry Vaccines Revenue Market Share by Type (2026-2031)
Table 58. Global Inactivated Poultry Vaccines Price (US$/Unit) by Type (2020-2025)
Table 59. Global Inactivated Poultry Vaccines Price (US$/Unit) by Type (2026-2031)
Table 60. Global Inactivated Poultry Vaccines Sales (K Units) by Application (2020-2025)
Table 61. Global Inactivated Poultry Vaccines Sales (K Units) by Application (2026-2031)
Table 62. Global Inactivated Poultry Vaccines Sales Market Share by Application (2020-2025)
Table 63. Global Inactivated Poultry Vaccines Sales Market Share by Application (2026-2031)
Table 64. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Inactivated Poultry Vaccines Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Inactivated Poultry Vaccines Revenue Market Share by Application (2020-2025)
Table 67. Global Inactivated Poultry Vaccines Revenue Market Share by Application (2026-2031)
Table 68. Global Inactivated Poultry Vaccines Price (US$/Unit) by Application (2020-2025)
Table 69. Global Inactivated Poultry Vaccines Price (US$/Unit) by Application (2026-2031)
Table 70. MSD Animal Health Company Information
Table 71. MSD Animal Health Description and Business Overview
Table 72. MSD Animal Health Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. MSD Animal Health Inactivated Poultry Vaccines Product
Table 74. MSD Animal Health Recent Developments/Updates
Table 75. Hester Biosciences Company Information
Table 76. Hester Biosciences Description and Business Overview
Table 77. Hester Biosciences Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Hester Biosciences Inactivated Poultry Vaccines Product
Table 79. Hester Biosciences Recent Developments/Updates
Table 80. Vaxxinova Company Information
Table 81. Vaxxinova Description and Business Overview
Table 82. Vaxxinova Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Vaxxinova Inactivated Poultry Vaccines Product
Table 84. Vaxxinova Recent Developments/Updates
Table 85. Elanco Company Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Elanco Inactivated Poultry Vaccines Product
Table 89. Elanco Recent Developments/Updates
Table 90. Dechra Company Information
Table 91. Dechra Description and Business Overview
Table 92. Dechra Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Dechra Inactivated Poultry Vaccines Product
Table 94. Dechra Recent Developments/Updates
Table 95. Kemin Industries Company Information
Table 96. Kemin Industries Description and Business Overview
Table 97. Kemin Industries Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Kemin Industries Inactivated Poultry Vaccines Product
Table 99. Kemin Industries Recent Developments/Updates
Table 100. Ceva Company Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ceva Inactivated Poultry Vaccines Product
Table 104. Ceva Recent Developments/Updates
Table 105. Venkys Company Information
Table 106. Venkys Description and Business Overview
Table 107. Venkys Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Venkys Inactivated Poultry Vaccines Product
Table 109. Venkys Recent Developments/Updates
Table 110. HIPRA Company Information
Table 111. HIPRA Description and Business Overview
Table 112. HIPRA Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. HIPRA Inactivated Poultry Vaccines Product
Table 114. HIPRA Recent Developments/Updates
Table 115. Japfa Comfeed Company Information
Table 116. Japfa Comfeed Description and Business Overview
Table 117. Japfa Comfeed Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Japfa Comfeed Inactivated Poultry Vaccines Product
Table 119. Japfa Comfeed Recent Developments/Updates
Table 120. Boehringer Ingelheim Company Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Boehringer Ingelheim Inactivated Poultry Vaccines Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Zoetis Company Information
Table 126. Zoetis Description and Business Overview
Table 127. Zoetis Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zoetis Inactivated Poultry Vaccines Product
Table 129. Zoetis Recent Developments/Updates
Table 130. Nisseiken Company Information
Table 131. Nisseiken Description and Business Overview
Table 132. Nisseiken Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Nisseiken Inactivated Poultry Vaccines Product
Table 134. Nisseiken Recent Developments/Updates
Table 135. KM Biologics Company Information
Table 136. KM Biologics Description and Business Overview
Table 137. KM Biologics Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. KM Biologics Inactivated Poultry Vaccines Product
Table 139. KM Biologics Recent Developments/Updates
Table 140. Laprovet Company Information
Table 141. Laprovet Description and Business Overview
Table 142. Laprovet Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Laprovet Inactivated Poultry Vaccines Product
Table 144. Laprovet Recent Developments/Updates
Table 145. Merck Company Information
Table 146. Merck Description and Business Overview
Table 147. Merck Inactivated Poultry Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Merck Inactivated Poultry Vaccines Product
Table 149. Merck Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Inactivated Poultry Vaccines Distributors List
Table 153. Inactivated Poultry Vaccines Customers List
Table 154. Inactivated Poultry Vaccines Market Trends
Table 155. Inactivated Poultry Vaccines Market Drivers
Table 156. Inactivated Poultry Vaccines Market Challenges
Table 157. Inactivated Poultry Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Poultry Vaccines
Figure 2. Global Inactivated Poultry Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inactivated Poultry Vaccines Market Share by Type: 2024 & 2031
Figure 4. Whole Cell Vaccine Product Picture
Figure 5. Component Vaccine Product Picture
Figure 6. Global Inactivated Poultry Vaccines Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Inactivated Poultry Vaccines Market Share by Application: 2024 & 2031
Figure 8. NDV
Figure 9. Marek ' s Disease
Figure 10. IBD
Figure 11. Infectious Bronchitis
Figure 12. Influenza
Figure 13. Others
Figure 14. Global Inactivated Poultry Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Inactivated Poultry Vaccines Market Size (2020-2031) & (US$ Million)
Figure 16. Global Inactivated Poultry Vaccines Sales (2020-2031) & (K Units)
Figure 17. Global Inactivated Poultry Vaccines Average Price (US$/Unit) & (2020-2031)
Figure 18. Inactivated Poultry Vaccines Report Years Considered
Figure 19. Inactivated Poultry Vaccines Sales Share by Manufacturers in 2024
Figure 20. Global Inactivated Poultry Vaccines Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Inactivated Poultry Vaccines Players: Market Share by Revenue in Inactivated Poultry Vaccines in 2024
Figure 22. Inactivated Poultry Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Inactivated Poultry Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 25. North America Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 26. United States Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 29. Europe Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 30. Germany Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Inactivated Poultry Vaccines Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Inactivated Poultry Vaccines Revenue Market Share by Region (2020-2031)
Figure 37. China Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 45. Latin America Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Inactivated Poultry Vaccines Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Inactivated Poultry Vaccines Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Inactivated Poultry Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Inactivated Poultry Vaccines by Type (2020-2031)
Figure 55. Global Revenue Market Share of Inactivated Poultry Vaccines by Type (2020-2031)
Figure 56. Global Inactivated Poultry Vaccines Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Inactivated Poultry Vaccines by Application (2020-2031)
Figure 58. Global Revenue Market Share of Inactivated Poultry Vaccines by Application (2020-2031)
Figure 59. Global Inactivated Poultry Vaccines Price (US$/Unit) by Application (2020-2031)
Figure 60. Inactivated Poultry Vaccines Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232